Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

The spinal cord stimulation technology from Swiss company Onward, called ARC-E-X, helps paralyzed people regain some mobility ...

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers have investigated this with promising results. For the first time, it was possible to identify patient ...

After a seven-year hiatus from football because of a life-changing injury, Shazier returns to his former team.

Spinal cord injuries are among the most serious medical conditions, often leading to life-altering physical, emotional, and ...

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, ...

Researchers have demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic ...

A Phase I clinical trial has demonstrated the long-term safety of neural stem cell transplantation for chronic spinal cord ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

For years, options for recovery have been limited, but a newly FDA-cleared external spinal stimulator, ARC-EX Therapy, which ...